Sing2016 M2SR H3N2 Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sing2016 M2SR H3N2 Influenza Vaccine, covering 2025-06-06 to 2025-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine [Phase 1]